Close

Monopar Announces Publication Demonstrating Potential Utility of MNPR-101 as an Imaging Agent to Improve Surgical Outcomes in Bladder Cancer

Go back to Monopar Announces Publication Demonstrating Potential Utility of MNPR-101 as an Imaging Agent to Improve Surgical Outcomes in Bladder Cancer
(NASDAQ: MNPR) Delayed: 0.64 -0.04 (5.88%)
Previous Close $0.68    52 Week High
Open $0.68    52 Week Low
Day High $0.68    P/E N/A 
Day Low $0.62    EPS
Volume 24,182